# Platelet Rich Plasma Eye Drops for Treatment of Ocular Surface Disease

> **NCT04608084** · PHASE4 · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 100 (estimated)

## Conditions studied

- Ocular Surface Disease
- Dry Eye Syndromes

## Interventions

- **BIOLOGICAL:** Autologous platelet rich plasma eye drops

## Key facts

- **NCT ID:** NCT04608084
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01
- **Primary completion:** 2022-01
- **Final completion:** 2023-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04608084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04608084, "Platelet Rich Plasma Eye Drops for Treatment of Ocular Surface Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04608084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*